Announcements Trials
Browse Landscape

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 144Neoplasms 130Prostatic Neoplasms 81Carcinoma, Non-Small-Cell Lung 79Lung Neoplasms 65Colorectal Neoplasms 46Carcinoma, Hepatocellular 37Stomach Neoplasms 33Multiple Myeloma 28Brain Neoplasms 28Uterine Cervical Neoplasms 27Melanoma 26Pancreatic Neoplasms 25Rectal Neoplasms 24Ovarian Neoplasms 24Head and Neck Neoplasms 24Colonic Neoplasms 23Urinary Bladder Neoplasms 22Hematologic Neoplasms 22Neoplasm Metastasis 21Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 19Esophageal Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Endometrial Neoplasms 17Recurrence 15Cardiovascular Diseases 15Thyroid Neoplasms 14Lymphoma 14Liver Neoplasms 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Hemorrhagic Stroke × Clear all
NCT05397106 2026-02-27

Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve

Integra LifeSciences Corporation

Active not recruiting
160 enrolled
CNS

Hemorrhagic Stroke, Brain Neoplasms, Hydrocephalus, Hydrocephalus, Normal Pressure, Pseudotumor Cerebri

Data powered by HemOnc (CC BY 4.0) Colophon âš¡